Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model
- 1 April 1997
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 27 (4) , 139-145
- https://doi.org/10.1016/s0732-8893(97)00026-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparative activity of temafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae using an in vitro pharmacodynamic model apparatusCurrent Therapeutic Research, 1994
- Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adultsThe Pediatric Infectious Disease Journal, 1993
- Clarithromycin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelAntimicrobial Agents and Chemotherapy, 1990
- Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humansAntimicrobial Agents and Chemotherapy, 1990
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycinAntimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolideAntimicrobial Agents and Chemotherapy, 1986
- Endobronchial pHAmerican Review of Respiratory Disease, 1983